Table of Content

Open Access iconOpen Access

REVIEW

crossmark

Current status of gene therapy in melanoma treatment

YONGLU WANG1,2,*, WEI YOU1, XUEMING LI3,4,*

1 College of Pharmacy, Nanjing Tech University, Nanjing, China
2 College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada
3 Nanjing Bestform Pharmaceutical Technology Co., Ltd., Nanjing, China
4 Postgraduate Department, Nanjing Tech University, Nanjing, China

* Address correspondence to: Yonglu Wang, email; Xueming Li, email

BIOCELL 2020, 44(2), 167-174. https://doi.org/10.32604/biocell.2020.09023

Abstract

Melanoma is the deadliest type of skin cancer and which has a high ability of metastasis. Surgery is an effective method to treat I or II stage melanoma patients. However, there are few treatment options for metastatic melanoma. Gene therapy is one of the attractive options and is considered as the future direction for treating melanoma. This review mainly discusses the properties and challenges of the various gene therapies in melanoma, especially the delivery systems and gene targeting.

Keywords


Cite This Article

APA Style
WANG, Y., YOU, W., LI, X. (2020). Current status of gene therapy in melanoma treatment. BIOCELL, 44(2), 167-174. https://doi.org/10.32604/biocell.2020.09023
Vancouver Style
WANG Y, YOU W, LI X. Current status of gene therapy in melanoma treatment. BIOCELL . 2020;44(2):167-174 https://doi.org/10.32604/biocell.2020.09023
IEEE Style
Y. WANG, W. YOU, and X. LI "Current status of gene therapy in melanoma treatment," BIOCELL , vol. 44, no. 2, pp. 167-174. 2020. https://doi.org/10.32604/biocell.2020.09023

Citations




cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 2713

    View

  • 2428

    Download

  • 0

    Like

Related articles

Share Link